Paul E Harrington, David J St Jean, Jeffrey Clarine, Thomas S Coulter, Michael Croghan, Adam Davenport, James Davis, Chiara Ghiron, Jonathan Hutchinson, Michael G Kelly, Fred Lott, Jenny Ying-Lin Lu, David Martin, Sean Morony, Steve F Poon, Elena Portero-Larragueta, Jeff D Reagan, Kelly A Regal, Andrew Tasker, Minghan Wang, Yuhua Yang, Guomin Yao, Qingping Zeng, Charles Henley, Christopher Fotsch
Index: Bioorg. Med. Chem. Lett. 20(18) , 5544-7, (2010)
Full Text: HTML
The discovery of a series of novel and orally efficacious type II calcimimetics, developed from the lead compound 1, is described herein. Compound 22 suppressed plasma PTH levels relative to vehicle when dosed orally in a rat pharmacodynamic model.Copyright (c) 2010 Elsevier Ltd. All rights reserved.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Dibenzylamine
CAS:103-49-1 |
C14H15N |
|
Spectrophotometric determination of folic acid in pharmaceut...
2002-08-15 [Anal. Biochem. 307(2) , 316-21, (2002)] |
|
Diastereoselective construction of syn-α-oxyamines via three...
2012-10-07 [Org. Biomol. Chem. 10(37) , 7536-44, (2012)] |
|
Kinetic study on the nitrosation of dibenzylamine in a model...
1994-11-01 [Food Chem. Toxicol. 32(11) , 1015-9, (1994)] |
|
Determination of imipramine in presence of iminodibenzyl and...
2003-11-24 [J. Pharm. Biomed. Anal. 33(4) , 775-82, (2003)] |
|
Dapsone and iminodibenzyl as novel reagents for the spectrop...
2001-03-01 [Anal. Sci. 17(3) , 439-42, (2001)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
